Reduced FOXP3+ regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms
about
Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell TherapyRegulatory T cells: Mechanisms of suppression and impairment in autoimmune liver diseaseThe Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in ChildhoodClinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current PerspectivesThe Immunogenetics of Autoimmune CholestasisLow-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseasesLoss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitisMechanisms of tissue injury in autoimmune liver diseases.Gene-disease associations identify a connectome with shared molecular pathways in human cholangiopathies.Immunology of hepatic diseases during pregnancy.Human intrahepatic regulatory T cells are functional, require IL-2 from effector cells for survival, and are susceptible to Fas ligand-mediated apoptosisEngineered Tolerance: Tailoring Development, Function, and Antigen-Specificity of Regulatory T Cells.Dietary and metabolic modulators of hepatic immunity.Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis.The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis.Regulatory T-cell conditioning endows activated effector T cells with suppressor function in autoimmune hepatitis/autoimmune sclerosing cholangitis.A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation.High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires.Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment.Primary Sclerosing Cholangitis
P2860
Q26742101-D8167F3F-27BC-4234-9174-5CC117DF31DBQ26827787-6D3A4E99-E016-4750-B368-736C2D8806E4Q28068996-5FEFAFAC-E417-41EB-8C2E-8EF5B665330BQ28069832-D3A26A3B-80BB-478D-A650-F754BD3BD37EQ28085346-2270CE10-2B8D-479D-B785-08C08CEF5490Q33650813-17035F34-8FF5-49F9-9982-03CA7403B9F1Q37127058-AD9571B0-6843-494E-BB4E-9558EA827EDDQ38235918-C50586F6-D220-4468-A753-841605A05A81Q38596985-4A8EB8EC-7E03-48D7-89CD-B6B3EA800E8CQ38870963-381EF7DA-F75E-4A18-A6A7-CB389489D510Q42108248-4E98E211-7EEB-4588-95E1-F4B056FAA9B1Q47150746-8096E027-B460-46B1-B3C7-A5560B847D0AQ48354848-CBEC806A-CACB-4BA6-9B32-E91849CE2F83Q52670887-94A5F03B-7C3D-40B5-B3EF-DEDFFF11FA43Q52733589-C3A14B7C-D8F6-4E4A-B99D-B3A1900D8CEAQ52766142-07A15A1F-F6C3-47BC-81A7-75E072E298CEQ52888768-F8C64D02-1712-4DA2-88BF-6210C068E915Q52925804-A0F4B8FB-A2CB-4A0F-88E4-C2DD5081FD57Q55497458-968B34F1-0595-4136-A857-A0B3099FE6FEQ56442935-E221F405-A0ED-4EF8-BAD5-9116F9340938
P2860
Reduced FOXP3+ regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms
description
article
@en
im Januar 2014 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2014
@uk
name
Reduced FOXP3+ regulatory T ce ...... with IL2RA gene polymorphisms
@en
Reduced FOXP3+ regulatory T ce ...... with IL2RA gene polymorphisms
@nl
type
label
Reduced FOXP3+ regulatory T ce ...... with IL2RA gene polymorphisms
@en
Reduced FOXP3+ regulatory T ce ...... with IL2RA gene polymorphisms
@nl
prefLabel
Reduced FOXP3+ regulatory T ce ...... with IL2RA gene polymorphisms
@en
Reduced FOXP3+ regulatory T ce ...... with IL2RA gene polymorphisms
@nl
P2093
P50
P1476
Reduced FOXP3(+) regulatory T ...... with IL2RA gene polymorphisms
@en
P2093
Alexander Quaas
Ansgar W Lohse
Björn Franke
Christiane Wiegard
Christina Weiler-Normann
Dorothee Schwinge
Frederike Wortmann
Johannes Herkel
Marcial Sebode
Moritz Peiseler
P304
P356
10.1016/J.JHEP.2013.12.027
P577
2014-01-08T00:00:00Z